| Fair trade regulator CCI has cleared Singapore government investment arm Temasek Holding's proposed acquisition of 10.16 per cent stake in Indian firm Intas Pharmaceuticals, saying the deal will not raise anti-competition concerns.
Under the proposed deal, Dunearn Investments (Mauritius) Pte. Ltd-a indirect subsidiary of Temasek-would acquire the stake from Mozart Ltd-a wholly owned subsidiary of ChrysCapital III LLC. In an order, the Competition Commission of India (CCI) said "that the proposed combination is not likely to have an appreciable adverse effort on competition in India"...............................................Full Article: Source
|